Sorrento Therapeutics, Inc. - Common Stock (NQ:SRNE)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 22, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sorrento Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Why Shares of Scilex Slumped This Week ↗

April 28, 2023

A stock sale and confusion regarding its parent company are factors dragging down the stock.

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 22, 2023

Via Benzinga

Why Sorrento Therapeutics Stock Crashed Today ↗

February 22, 2023

Any euphoria after the biotech stock's big jump yesterday didn't last long.

Via The Motley Fool

Meta Platforms Layoffs 2023: Are More Facebook Job Cuts Coming? ↗

February 22, 2023

Meta Platforms (META) layoffs are a hot topic on Wednesday as reports spread that the Facebook parent company is planning more job cuts.

Via InvestorPlace

Alphabet Layoffs 2023: What to Know About the Latest Google Job Cuts ↗

February 22, 2023

Alphabet (GOOGL,GOOG) layoffs are worth checking on Wednesday as recent reports claim Google job cuts are coming to Ireland.

Via InvestorPlace

Why Sorrento Therapeutics Stock Is Soaring Today ↗

February 22, 2023

Sorrento Therapeutics Inc (NASDAQ: SRNE) shares are rising on Wednesday after the U.S.

Via Benzinga

Why Sorrento Therapeutics Stock Is Crashing Today ↗

February 13, 2023

A bankruptcy filing is weighing on the drugmaker's shares today.

Via The Motley Fool

Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 22, 2023

Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous...

Via Benzinga

The $75 Million Reason Sorrento (SRNE) Stock Is Moving Today ↗

February 22, 2023

SRNE stock is moving this morning after soaring about 25% yesterday. The company recently declared bankruptcy after losing a lawsuit.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 22, 2023

Via Benzinga

Why Wag! Group Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗

February 22, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

February 22, 2023

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to watch on Wednesday morning!

Via InvestorPlace

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 21, 2023

Gainers Arbe Robotics Ltd. (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.

Via Benzinga

Why Shares of Sorrento Therapeutics Are Up Today ↗

February 21, 2023

The company is walling off subsidiary Scilex from its bankruptcy proceedings.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 21, 2023

Via Benzinga

Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket ↗

February 21, 2023

Gainers Troika Media Group Inc (NASDAQ: TRKA) shares rose 65.9% to $0.37 in pre-market trading after dropping 4% on Friday.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 20, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

February 17, 2023

Via Benzinga

Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 16, 2023

Gainers TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 16, 2023

Via Benzinga

Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

February 14, 2023

Gainers Amesite Inc. (NASDAQ: AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

February 14, 2023

During Tuesday, 40 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

February 13, 2023

Via Benzinga

5 Investors Betting Big on Sorrento Therapeutics (SRNE) Stock ↗

February 13, 2023

SRNE stock is plummeting lower after the company disclosed that it had filed for Chapter 11 bankruptcy protection.

Via InvestorPlace

Dow Gains Over 300 Points; S&P 500 Up 1% ↗

February 13, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 300 points on Monday. The Dow traded up 1.01% to 34,211.29 while the NASDAQ rose 1.52% to 11,896.33. The S&P 500...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 13, 2023

Via Benzinga

Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet ↗

February 13, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1.5% on Monday. The Dow traded up 0.96% to 34,193.83 while the NASDAQ rose 1.52% to 11,896.75. The S&P 500...

Via Benzinga

Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 13, 2023

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 120.5% to $1.02 after jumping over 72% on Friday.

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

February 13, 2023

On Monday, 42 companies hit new 52-week lows.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.